Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    musculoskeletal

    Sarcopenia

    Also known as: Age-related skeletal muscle loss, Age-related muscle wasting, Age-associated loss of muscle strength

    Sarcopenia is a progressive geriatric syndrome characterised by the decline of skeletal muscle mass and strength, resulting in impaired physical performance and increased risks of falls and disability. Diagnosis necessitates comprehensive evaluation of nutritional status, physical activity, pharmacotherapy, and comorbid conditions, avoiding the attribution of muscle atrophy solely to physiological senescence. Primary management involves structured resistance training, nutritional intervention, and medical stabilisation of underlying pathologies. Within a TCM framework, acupuncture and herbal medicine may provide adjunctive, symptom-focused support, but do not substitute for medical diagnostics or physical rehabilitation. The cited evidence—comprising a bibliometric analysis, cross-sectional associations, molecular investigations, and a corrigendum—does not establish clinical efficacy for acupuncture or the specific herbal formulas. Traditional patterns serve as assessment frameworks rather than biomedical diagnoses or validated predictors of therapeutic outcomes.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain a supervised programme of resistance and proprioceptive exercises, incorporating adequate recovery periods.
    • •Include protein-containing foods across meals; consult a clinical dietitian regarding low intake, dysphagia, or specific renal dietary restrictions.
    • •Mitigate fall risks through the use of supportive footwear, optimal lighting, clearance of environmental hazards, and correctly fitted mobility aids.
    • •Prioritise sleep hygiene and socialised meals; systematically monitor fluctuations in appetite, weight, and capacity for activities of daily living.

    Cautions & Contraindications

    See sources
    • •The supplied abstracts establish neither acupuncture efficacy nor formula-specific safety. Do not use these traditional options to replace rehabilitation, nutritional care or investigation of weakness. Reference 3 is a bibliometric map, not a treatment recommendation or safety trial.[]
    • •Defer elective needling when the patient is acutely unwell or cannot be positioned safely; avoid infected or damaged skin. Frailty, anticoagulation and very low tissue mass require individual procedural risk assessment. These are general safety precautions; reference 3 provides context rather than direct procedural evidence.[]
    • •Do not interpret malnutrition-pattern associations as a reason to prescribe herbs without checking medicines, organ function and nutritional needs. Reference 4 is cross-sectional and does not validate the efficacy, interactions or safety of any formula.[]
    • •Do not recommend iron manipulation, chelation or antioxidant treatment on the basis of ferroptosis-related gene findings. Reference 1 uses dystrophy datasets and mouse validation, not a clinical sarcopenia intervention trial.[]

    When to reassess or seek care again

    See sources

    Record baseline weight trend, appetite, falls, walking tolerance and functional goals; measure grip strength and a standardised chair-rise or gait-speed test when safe. Review tolerability and symptoms within 2–4 weeks and functional change at 6–8 weeks using the same methods. Refer promptly for declining performance, recurrent falls, persistent weight loss or new neurological symptoms. Stop or revise adjunctive treatment if adverse effects occur or agreed goals show no meaningful progress; subjective symptom relief alone does not establish increased muscle mass.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Aging · 2026
    2. Journal of ethnopharmacology · 2026
    3. Frontiers in aging · 2026
    4. Complementary medicine research · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.